16 December 2009 in The Journal of Physical Chemistry A
18 July 2011 in Physical Chemistry Chemical Physics
A cost-effective computational methodology designed to study astatine (At) chemistry in aqueous solution has been established. It is based on two-component spin–orbit density functional theory calculations and solvation calculations using the conductor-like polarizable continuum model in conjunction with specific astatine cavities. Theoretical calculations are confronted with experimental data measured for complexation reactions between metallic forms of astatine (At+ and AtO+) and inorganic ligands (Cl−, Br− and SCN−). For each reaction, both 1 ∶ 1 and 1 ∶ 2 complexes are evidenced. The experimental trends regarding the thermodynamic constants (K) can be reproduced qualitatively and quantitatively. The mean signed error on computed Log K values is −0.4, which corresponds to a mean signed error smaller than 1 kcal mol−1 on free energies of reaction. Theoretical investigations show that the reactivity of cationic species of astatine is highly sensitive to spin–orbit coupling and solvent effects. At the moment, the presented computational methodology appears to be the only tool to gain an insight into astatine chemistry at a molecular level.
20 February 2013 in The Journal of Physical Chemistry A
1 June 2016 in European Journal of Medicinal Chemistry
1 June 2009 in Inorganica Chimica Acta
11 May 2012 in Dalton Transactions
The in vivo212Pb/212Bi generator is promising for application in targeted alpha therapy (TAT) of cancer. One main limitation of its therapeutic application is due to potential release of 212Bi from the radioconjugate upon radioactive decay of the mother nuclide 212Pb, potentially leading to irradiation of healthy tissue. The objective of the present work is to assess whether the chelate CHX-A′′-DTPA (N-(2-aminoethyl)-trans-1,2-diaminocyclohexane-N,N′,N′′-pentaacetic acid) bound to a biological carrier molecule may be able to re-complex released 212Bi under in vivo conditions to limit its translocation from the target site. CHX-A′′-DTPA was bound to bovine gamma globulin (BGG) to mimic a model conjugate and the stability of the Bi-CHX-A′′-DTPA-BGG conjugate was studied in blood serum by ultrafiltration. TRLFS experiments using Cm(III) as a fluorescent probe demonstrated that linking CHX-A′′-DTPA to BGG does not affect the coordination properties of the ligand. Furthermore, comparable stability constants were observed between Bi(III) and free CHX-A′′-DTPA, BGG-bound CHX-A′′-DTPA and DTPA. The complexation constants determined between Bi(III) and the chelate molecules are sufficiently high to allow ultra trace amounts of the ligand to efficiently compete with serum transferrin controlling Bi(III) speciation in blood plasma conditions. Nevertheless, CHX-A′′-DTPA is not able to complex Bi(III) generated in blood serum because of the strong competition between Bi(III) and Fe(II) for the ligand. In other words, CHX-A′′-DTPA is not “selective” enough to limit Bi(III) release in the body when applying the 212Pb/212Bi in vivo generator.